NCT03703687

Brief Summary

This is a pilot study consisting of mixed-methods, pre-post evaluation of a gratitude intervention (gratitude letter and visit) on palliative care patients and their caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 12, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

November 27, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2020

Completed
Last Updated

December 19, 2020

Status Verified

December 1, 2020

Enrollment Period

1.9 years

First QC Date

September 28, 2018

Last Update Submit

December 17, 2020

Conditions

Keywords

palliative caregratitudepositive psychology

Outcome Measures

Primary Outcomes (2)

  • Change in relationship quality for patients and caregivers

    The quality of the relationship between the palliative patient and his/her caregiver will be measured with the Couple Satisfaction Index (CSI-4; "total score" range from 0 to 21, higher scores indicating a better quality of relationship).

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

  • Change in relationship quality for patients and caregivers

    The quality of the relationship between the palliative patient and his/her caregiver will be also measured with the Positive Negative Relationship Quality Scale (PNRQ; "positive subscale" range from 0 to 48 and "negative subscale" range from 0 to 48, with higher scores indicating higher quality of relationship).

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

Secondary Outcomes (6)

  • Change in subjective quality of life for patients

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

  • Change in subjective quality of life for caregivers

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

  • Change in psychological distress for patients

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

  • Change in psychological distress for caregivers

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

  • Change in burden for patients

    Baseline approx. 5 days before intervention; post-intervention approx.10 days after intervention

  • +1 more secondary outcomes

Study Arms (1)

Gratitude intervention

EXPERIMENTAL

The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.

Behavioral: Gratitude intervention

Interventions

The intervention will be proposed to both the patient and the caregiver and consists of two steps: the "gratitude letter" and the "gratitude visit". In the "gratitude letter", the individual writes about his feelings of gratitude through a letter, based on a written instruction. The "gratitude visit" consists of an extension of the gratitude letter where the writer of the letter (i) either personally reads the letter to the beneficent or (ii) gives it to him and asks him to read it in his presence or later in his absence.

Also known as: gratitude letter, gratitude visit
Gratitude intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18
  • progressive disease
  • reduced life expectancy
  • enrolment in palliative care
  • stable state for the previous 24h assessed by the physician or the nurse in charge of the patient
  • informed consent signed by patient
  • For each patient, the identification of a close family or friend caregiver (fulfilling the below criteria\*) and who accepts to participate in the trial (by signing an informed consent)
  • In this research, a caregiver is defined as "a person who devotes time to help a family member or a friend affected in her/his health or autonomy. The caregiver assures, in a non-professional and regular way, a presence and a support to help her/him in his difficulties and assures her/his safety. The caregiver can be a friend, a family member or a neighbour" (Vaud canton definition). This definition will be the basis for the palliative patient to identify his caregiver.

You may not qualify if:

  • Person completely isolated socially, no family or friend caregiver identified
  • Significant cognitive or psychiatric disorders which would affect the ability to give informed consent for this research
  • Severe communication problems (foreign language, deafness, etc.).
  • Age \>18
  • Identified as the caregiver by the palliative patient (see above)
  • prior agreement of the patient for the participation of the caregiver
  • Psychiatric and cognitive disorders which would affect the ability to give informed consent for this research based on the information reported by the clinical team in charge of the patient and the personal evaluation of the research collaborator.
  • Communication problems (foreign language, deafness, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Rive-Neuve Foundation

Blonay, Canton of Vaud, 1807, Switzerland

Location

Lausanne University hospital, Palliative and supportive care service

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Fribourg University hospital, Unité et Accueil de jour de soins palliatifs

Fribourg, 1708, Switzerland

Location

Study Officials

  • Mathieu Bernard

    Palliative and Supportive care service of the Centre Hospitalier Universitaire Vaudois

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This clinical trial has a single arm: all the dyads will go through all the steps (apart from the qualitative assessment which are facultatives).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Research Unit of the palliative and supportive care service

Study Record Dates

First Submitted

September 28, 2018

First Posted

October 12, 2018

Study Start

November 27, 2018

Primary Completion

October 8, 2020

Study Completion

October 8, 2020

Last Updated

December 19, 2020

Record last verified: 2020-12

Locations